{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:53:49Z","timestamp":1773280429947,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alopecia is one of the most common adverse effects of chemotherapy. It reduces the patient\u2019s self-esteem and quality of life and the effect of therapy. Scalp cooling is the only verified current method for prevention but success is not guaranteed, particularly after receiving anthracycline-based combinations.<\/jats:p>\n                <jats:p>Low-level light therapy has been clinically proven to inhibit the progress of androgenic alopecia. A previous study using human subjects shows limited benefits for low-level light therapy for patients who suffer chemotherapy-induced alopecia but an increase in the number of probes and the optimization of light sources may improve the efficacy. This study determines the efficacy of low-level light therapy for the prevention of chemotherapy-induced hair loss for patients with breast cancer using a randomized controlled trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred six eligible breast cancer patients were randomly distributed into a low-level light therapy group and a control group, after receiving chemotherapy. Subjects in the low-level light therapy group received 12 courses of intervention within 4 weeks. Subjects in the control group received no intervention but were closely monitored.<\/jats:p>\n                <jats:p>The primary outcome is measured as the difference in the hair count in a target area between the baseline and at the end of week 4, as measured using a phototrichogram (Sentra scalp analyzer). The secondary outcomes include the change in hair count at the end of week 1, week 2, and week 3 and hair width at the end of week 1, week 2, week 3, and week 4, as measured using a phototrichogram, and the change in distress, the quality of life, and self-esteem due to chemotherapy-induced alopecia, at the end of week 4, as measured using a questionnaire.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study improves cancer patients\u2019 quality of life and provides clinical evidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Registered at ClinicalTrials.gov\u2014<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05397457\">NCT05397457<\/jats:ext-link> on 1 June 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07823-x","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T08:02:19Z","timestamp":1701763339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Cong-Xian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsien","family":"Shiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-0269","authenticated-orcid":false,"given":"Yuan-Chieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"5","key":"7823_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","volume":"95","author":"GB Silva","year":"2020","unstructured":"Silva GB, Ciccolini K, Donati A, Hurk CVD. Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol. 2020;95(5):631\u20137.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"7823_CR2","first-page":"562","volume":"25","author":"VJ Dorr","year":"1998","unstructured":"Dorr VJ. A practitioner\u2019s guide to cancer-related alopecia. Semin Oncol. 1998;25(5):562\u201370.","journal-title":"Semin Oncol"},{"issue":"5","key":"7823_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","volume":"76","author":"A Fonia","year":"2017","unstructured":"Fonia A, Cota C, Setterfield JF, Goldberg LJ, Fenton DA, Stefanato CM. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients. J Am Acad Dermatol. 2017;76(5):948\u201357.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"7823_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, van den Hurk C, Goldfarb S, Jimenez JJ, Rossi AM, et al. Hair disorders in cancer survivors. J Am Acad Dermatol. 2019;80(5):1199\u2013213.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"7823_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","volume":"24","author":"D Kang","year":"2019","unstructured":"Kang D, Kim IR, Choi EK, Im YH, Park YH, Ahn JS, et al. Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study. Oncologist. 2019;24(3):414\u201320.","journal-title":"Oncologist"},{"issue":"11","key":"7823_CR6","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/annonc\/mds095","volume":"23","author":"N Kluger","year":"2012","unstructured":"Kluger N, Jacot W, Frouin E, Rigau V, Poujol S, Dereure O, et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann Oncol. 2012;23(11):2879\u201384.","journal-title":"Ann Oncol"},{"issue":"3","key":"7823_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","volume":"171","author":"M Mart\u00edn","year":"2018","unstructured":"Mart\u00edn M, de la Torre-Montero JC, L\u00f3pez-Tarruella S, Pinilla K, Casado A, Fernandez S, et al. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat. 2018;171(3):627\u201334.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7823_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/030089161009600214","volume":"96","author":"PK Auvinen","year":"2010","unstructured":"Auvinen PK, M\u00e4h\u00f6nen UA, Soininen KM, Paananen PK, Ranta-Koponen PH, Saavalainen IE, et al. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori. 2010;96(2):271\u20135.","journal-title":"Tumori"},{"issue":"2","key":"7823_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00520-008-0475-4","volume":"17","author":"F Mols","year":"2009","unstructured":"Mols F, van den Hurk CJ, Vingerhoets AJ, Breed WP. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. Supportive Care Cancer. 2009;17(2):181\u20139.","journal-title":"Supportive Care Cancer"},{"issue":"6","key":"7823_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/(SICI)1099-1611(199911\/12)8:6<467::AID-PON400>3.0.CO;2-P","volume":"8","author":"E Maunsell","year":"1999","unstructured":"Maunsell E, Brisson C, Dubois L, Lauzier S, Fraser A. Work problems after breast cancer: an exploratory qualitative study. Psycho-oncology. 1999;8(6):467\u201373.","journal-title":"Psycho-oncology"},{"issue":"10","key":"7823_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/pon.788","volume":"13","author":"ML Luoma","year":"2004","unstructured":"Luoma ML, Hakamies-Blomqvist L. The meaning of quality of life in patients being treated for advanced breast cancer: a qualitative study. Psycho-oncology. 2004;13(10):729\u201339.","journal-title":"Psycho-oncology"},{"key":"7823_CR12","volume-title":"Understanding alopecia","author":"N Hunt","year":"2004","unstructured":"Hunt N, McHale SJLS. Understanding alopecia; 2004."},{"issue":"2","key":"7823_CR13","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","volume":"14","author":"R Paus","year":"2013","unstructured":"Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013;14(2):e50\u20139.","journal-title":"Lancet Oncol"},{"issue":"5","key":"7823_CR14","doi-asserted-by":"publisher","first-page":"E442","DOI":"10.1002\/ijc.29115","volume":"136","author":"H Shin","year":"2015","unstructured":"Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015;136(5):E442\u201354.","journal-title":"Int J Cancer"},{"issue":"7","key":"7823_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","volume":"18","author":"MM Komen","year":"2013","unstructured":"Komen MM, Smorenburg CH, van den Hurk CJ, Nortier JW. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 2013;18(7):885\u201391.","journal-title":"Oncologist"},{"issue":"2","key":"7823_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10103-011-0953-7","volume":"27","author":"TC Wikramanayake","year":"2012","unstructured":"Wikramanayake TC, Rodriguez R, Choudhary S, Mauro LM, Nouri K, Schachner LA, et al. Effects of the Lexington LaserComb on hair regrowth in the C3H\/HeJ mouse model of alopecia areata. Lasers Med Sci. 2012;27(2):431\u20136.","journal-title":"Lasers Med Sci"},{"issue":"2","key":"7823_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/lsm.22170","volume":"46","author":"P Avci","year":"2014","unstructured":"Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014;46(2):144\u201351.","journal-title":"Lasers Surg Med"},{"issue":"1","key":"7823_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.det.2012.08.018","volume":"31","author":"S Kalia","year":"2013","unstructured":"Kalia S, Lui H. Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis. Dermatol Clin. 2013;31(1):193\u2013200.","journal-title":"Dermatol Clin"},{"issue":"9","key":"7823_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/lsm.20549","volume":"39","author":"TN Demidova-Rice","year":"2007","unstructured":"Demidova-Rice TN, Salomatina EV, Yaroslavsky AN, Herman IM, Hamblin MR. Low-level light stimulates excisional wound healing in mice. Lasers Surg Med. 2007;39(9):706\u201315.","journal-title":"Lasers Surg Med"},{"issue":"3","key":"7823_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/14764172.2017.1383613","volume":"20","author":"EM Dodd","year":"2018","unstructured":"Dodd EM, Winter MA, Hordinsky MK, Sadick NS, Farah RS. Photobiomodulation therapy for androgenetic alopecia: a clinician\u2019s guide to home-use devices cleared by the Federal Drug Administration. J Cosmet Laser Ther. 2018;20(3):159\u201367.","journal-title":"J Cosmet Laser Ther"},{"issue":"8","key":"7823_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/dsu.12200","volume":"39","author":"H Kim","year":"2013","unstructured":"Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39(8):1177\u201383.","journal-title":"Dermatol Surg"},{"issue":"10","key":"7823_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/scd.2016.0332","volume":"26","author":"K Yin","year":"2017","unstructured":"Yin K, Zhu R, Wang S, Zhao RC. Low-level laser effect on proliferation, migration, and antiapoptosis of mesenchymal stem cells. Stem Cells Dev. 2017;26(10):762\u201375.","journal-title":"Stem Cells Dev"},{"issue":"SUPPL 33","key":"7823_CR23","first-page":"S19","volume":"53","author":"I Stadler","year":"2021","unstructured":"Stadler I, Pennino R, Lanzafame R. Analysis of the effects of red light photobiomodulation therapy at 655nm on female breast cancer patients with chemotherapyinduced alopecia. Lasers Surg Med. 2021;53(SUPPL 33):S19.","journal-title":"Lasers Surg Med"},{"issue":"4","key":"7823_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1051\/bmdcn\/2017070422","volume":"7","author":"SV Moskvin","year":"2017","unstructured":"Moskvin SV. Only lasers can be used for low level laser therapy. BioMedicine. 2017;7(4):22.","journal-title":"BioMedicine"},{"issue":"4","key":"7823_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/pho.2005.23.431","volume":"23","author":"L Hode","year":"2005","unstructured":"Hode L. The importance of the coherency. Photomed Laser Surg. 2005;23(4):431\u20134.","journal-title":"Photomed Laser Surg"},{"key":"7823_CR26","unstructured":"Savarese DJUW, MA: UpToDate. Common terminology criteria for adverse events. 2013."},{"key":"7823_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17.","journal-title":"J Educ Eval Health Prof"},{"issue":"10","key":"7823_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pon.3531","volume":"23","author":"EK Choi","year":"2014","unstructured":"Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psycho-oncology. 2014;23(10):1103\u201310.","journal-title":"Psycho-oncology"},{"issue":"9","key":"7823_CR29","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1007\/s00520-019-05284-0","volume":"28","author":"W Cong","year":"2020","unstructured":"Cong W, Wu Y, Liu L, Hu M, Zhou C. A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients. Supportive Care Cancer. 2020;28(9):4327\u201336.","journal-title":"Supportive Care Cancer"},{"issue":"12","key":"7823_CR30","doi-asserted-by":"publisher","first-page":"e0209344","DOI":"10.1371\/journal.pone.0209344","volume":"13","author":"HW Lin","year":"2018","unstructured":"Lin HW, Li CI, Lin FJ, Chang JY, Gau CS, Luo N, et al. Valuation of the EQ-5D-5L in Taiwan. PLoS One. 2018;13(12):e0209344.","journal-title":"PLoS One"},{"key":"7823_CR31","unstructured":"Yabin X, Aixia MJSMPJ. Study on reliability and validity of Chinese version of EQ-5D-5L. 2013;9:40-3."},{"issue":"2","key":"7823_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-019-05169-0","volume":"175","author":"DH Marks","year":"2019","unstructured":"Marks DH, Okhovat JP, Hagigeorges D, Manatis-Lornell AJ, Isakoff SJ, Lacouture ME, et al. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat. 2019;175(2):267\u201376.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"7823_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/pon.727","volume":"12","author":"WC Chie","year":"2003","unstructured":"Chie WC, Chang KJ, Huang CS, Kuo WH. Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psycho-oncology. 2003;12(7):729\u201335.","journal-title":"Psycho-oncology"},{"issue":"1","key":"7823_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1023\/A:1022070220328","volume":"12","author":"WC Chie","year":"2003","unstructured":"Chie WC, Hong RL, Lai CC, Ting LL, Hsu MM. Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res. 2003;12(1):93\u20138.","journal-title":"Qual Life Res"},{"issue":"1","key":"7823_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/B:QURE.0000015295.74812.06","volume":"13","author":"WC Chie","year":"2004","unstructured":"Chie WC, Yang CH, Hsu C, Yang PC. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Qual Life Res. 2004;13(1):257\u201362.","journal-title":"Qual Life Res"},{"key":"7823_CR36","unstructured":"Rosenberg M. Princeton University Press; 2015."},{"issue":"1","key":"7823_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","volume":"28","author":"RM Tr\u00fceb","year":"2009","unstructured":"Tr\u00fceb RM. Chemotherapy-induced alopecia. J Cutan Med Surg. 2009;28(1):11\u20134.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"7823_CR38","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","volume":"67","author":"SY Chon","year":"2012","unstructured":"Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):e37\u201347.","journal-title":"J Am Acad Dermatol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07823-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T08:03:56Z","timestamp":1701763436000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07823-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7823"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07823-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Chang Gung Medical Foundation Institutional Review Board (protocol no. 202200395A3). Informed consent is obtained from all study participants or their legal guardian. An audit is conducted once a year by the independent data monitoring expert and Chang Gung Medical Foundation Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No personal identifying information is published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"789"}}